These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Association between inflammatory response and outcome after subarachnoid haemorrhage. Bjerkne Wenneberg S; Odenstedt Hergès H; Svedin P; Mallard C; Karlsson T; Adiels M; Naredi S; Block L Acta Neurol Scand; 2021 Feb; 143(2):195-205. PubMed ID: 32990943 [TBL] [Abstract][Full Text] [Related]
8. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications. Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369 [No Abstract] [Full Text] [Related]
9. Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage. Gueorguieva I; Clark SR; McMahon CJ; Scarth S; Rothwell NJ; Tyrrell PJ; Hopkins SJ; Rowland M Br J Clin Pharmacol; 2008 Mar; 65(3):317-25. PubMed ID: 17875190 [TBL] [Abstract][Full Text] [Related]
10. Effects of distance and transport method on intervention and mortality in aneurysmal subarachnoid hemorrhage. Weyhenmeyer J; Guandique CF; Leibold A; Lehnert S; Parish J; Han W; Tuchek C; Pandya J; Leipzig T; Payner T; DeNardo A; Scott J; Cohen-Gadol AA J Neurosurg; 2018 Feb; 128(2):490-498. PubMed ID: 28186453 [TBL] [Abstract][Full Text] [Related]
11. Effects of decompressive craniectomy on functional outcomes and death in poor-grade aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Alotaibi NM; Elkarim GA; Samuel N; Ayling OGS; Guha D; Fallah A; Aldakkan A; Jaja BNR; de Oliveira Manoel AL; Ibrahim GM; Macdonald RL J Neurosurg; 2017 Dec; 127(6):1315-1325. PubMed ID: 28059660 [TBL] [Abstract][Full Text] [Related]
12. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. Endo H; Hagihara Y; Kimura N; Takizawa K; Niizuma K; Togo O; Tominaga T J Neurosurg; 2022 Dec; 137(6):1707-1717. PubMed ID: 35364589 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Greenhalgh AD; Brough D; Robinson EM; Girard S; Rothwell NJ; Allan SM Dis Model Mech; 2012 Nov; 5(6):823-33. PubMed ID: 22679224 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository. Jaja BN; Lingsma H; Schweizer TA; Thorpe KE; Steyerberg EW; Macdonald RL; J Neurosurg; 2015 Mar; 122(3):644-52. PubMed ID: 25554825 [TBL] [Abstract][Full Text] [Related]
18. Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage. Zhao B; Yang H; Zheng K; Li Z; Xiong Y; Tan X; Zhong M; J Neurosurg; 2017 Jun; 126(6):1764-1771. PubMed ID: 27367238 [TBL] [Abstract][Full Text] [Related]
19. Levels of Interleukin-1β, Interleukin-18, and Tumor Necrosis Factor-α in Cerebrospinal Fluid of Aneurysmal Subarachnoid Hemorrhage Patients May Be Predictors of Early Brain Injury and Clinical Prognosis. Lv SY; Wu Q; Liu JP; Shao J; Wen LL; Xue J; Zhang XS; Zhang QR; Zhang X World Neurosurg; 2018 Mar; 111():e362-e373. PubMed ID: 29277532 [TBL] [Abstract][Full Text] [Related]